Mdm2

信号通路图

研究领域

抑制剂选择性比较

特异性亚型抑制剂

Mdm2产品

所有产品 Mdm2抑制剂(9) Mdm2拮抗剂(4) 新Mdm2产品

产品目录	产品描述	文献引用	实验数据
S2678	NSC 207895 NSC 207895抑制MDMX，IC50为2.5 μM，促进p53稳定/激活和DNA损伤，也调节MDM2（E3连接酶）。	Oncol Lett, 2018, 15(2):1673-1679 Stem Cell Reports, 2016, 7(6):1140-1151	Median overall survival of mice (n = 5 mice in vehicle and PYR-41; n = 4 mice in NSC group) inoculated with IOWA-1T xenografts were increased to 43 ± 0.5 and 39 ± 2 days with PYR-41 (PYR) and NSC-207895 (NSC), respectively, compared with a vehicle-treated control group 33 ± 1 days (*p < 0.05).
S8059	Nutlin-3a Nutlin-3a是Nutlin-3的活性对映体，抑制p53/MDM2相互作用，无细胞试验中IC50为90 nM。	Cell Stem Cell, 2019, 25(2):258-272 PLoS Pathog, 2019, 15(2):e1007442 Cell Death Dis, 2019, 10(4):282	Nutlin-3a preserved p53 expression without influencing high glucose (HG)-induced podocyte impairment. A-D: cultured podocytes were pre-treated by nutlin-3a for 2 hrs before subjected to HG treatment. Western blotting gel documents (A) and summarized data (B) showing the expression of p53 and MDM2 in podocytes under HG exposure for 24 hrs. n = 4. Western blotting gel documents (C) and summarized data (D) showing the expression of Desmin in podocytes under HG exposure for 24 hrs. n = 3. *P < 0.05 vs. Ctrl, #P < 0.05 vs. Vehl + HG. Ctrl: control; Vehl: vehicle; nutlin-3a: nutlin-3a treatment.
S7030	RG-7112 RG7112 (RO5045337)是一种口服具有活性的选择性p53-MDM2抑制剂，HTRF IC50为18 nM。	Nat Commun, 2019, 10(1):2189 Cancer Biother Radiopharm, 2019, 34(4):252-257 Nat Commun, 2018, 9(1):2024
S8703^New	Milademetan (DS-3032b) Milademetan (DS-3032b) is a novel potent MDM2 inhibitor that inhibits MDM2-p53 interaction with an IC50 of 5.57 nM in the HTRF assay.
S7875	NVP-CGM097 NVP-CGM097是一种高效的、选择性的MDM2抑制剂， Ki值为1.3 nM。它与MDM2蛋白的p53结合位点结合，破坏其蛋白间相互作用，导致p53通路的激活。	Viruses, 2019, 11(8) Mol Pharmacol, 2016, 89(2):233-42 Carcinogenesis, 2013, 34(2):436-45	(C) SACi2 effects are dependent on MT-kinetochore attachments. The graph shows percentage of cells undergoing forced mitotic exit by SACi2 or DMSO in various pretreatment conditions (mean ± SEM, three independent assays). Nocodazole (Noc) was used at 70 nM and 3 μM, vinblastine (Vbl) at 1 μM, taxol (Tx) at 600 nM and monastrol (Mon) at 100 μM concentrations and were added 8 h before addition of DMSO or SACi2. MG132 (20 μM) was added 1 h before nocodazole.
S8403	MX69 MX69是MDM2/XIAP抑制剂，其结合MDM2 RING 蛋白的Kd值为2.34 μM。用于治疗癌症。
S8606	HDM201,Siremadlin HDM201是一种新型的、高效的、选择性的p53-Mdm2 interaction抑制剂，对Mdm2的亲合常数在皮摩尔范围内，对Mdm2的选择性是对Mdm4的1000倍以上。
S7205	Idasanutlin (RG-7388) Idasanutlin (RG-7388)是一种有效的选择性p53-MDM2抑制剂,其IC50为6 nM。其体外结合力和在细胞中的效力、选择性都有极大的改善。	Cancer Cell, 2019, 35(2):204-220 Cells, 2019, 8(6) Nat Commun, 2018, 9(1):2024
S2341	(-)-Parthenolide (-)-Parthenolide, Nuclear Factor-κB抑制剂，可特异性地耗尽HDAC1蛋白，而不影响其他I/II类 HDACs。促进MDM2的泛素化并激活p53的细胞功能。	Br J Haematol, 2019, 187(1):49-64 Biochem Biophys Res Commun, 2018, 501(1):246-252 Oncol Rep, 2018, 39(3):1181-1190	G. To evaluate effects of IKBKE/TBK1 inhibition on NF-κB signaling in Ewing, TC32 cells were incubated with CYT387 for six hours prior to stimulation with TNF-α (30 ng/mL). IκBα degradation was measured by harvesting TC32 cells thirty minutes after stimulation with TNF-α. TNF-α stimulation resulted in degradation of IκBα, and this effect was attenuated with CYT387 treatment. Parthenolide, an inhibitor of IκBα phosphorylation was used as a positive control. Similar effects of CYT387 activity were seen in HEK-293T cells which also express IKBKΕ. Nuclear extracts were prepared from TC32 cells harvested following forty-five minutes of TNF-α stimulation. Treatment with CYT387 resulted in decreased nuclear localization of NF-κB family proteins RelA/p65 and c-Rel. There was a modest impairment of p50 nuclear localization as compared to parthenolide and DMSO controls and no change in p52 nuclear localization. RelB (not shown) is not expressed in TC32 cells
S1061	Nutlin-3 Nutlin-3是一种有效的，选择性Mdm2(它自身和p53的环指依赖性泛素蛋白连接酶)拮抗剂，无细胞试验中IC50为90 nM；可稳定p53缺陷细胞中的p73。	Virology, 2020, 539:1-10 Cell Rep, 2019, 29(5):1249-1260 Cell Death Differ, 2019, 10.1038/s41418-019-0338-1	Ubiquitination of p53 in vivo by BIRC6 in the presence of Nutlin-3. Cells were treated with Nutlin-3 (20 uM, 24 h) before harvest. Cell lysates were immunoprecipitated with anti-p53 antibody and immunoblotted by anti-ubiquitin antibody.
S8065	Nutlin-3b Nutlin-3b是一种p53/MDM2拮抗剂或抑制剂，IC50值为13.6μM，是Nutlin-3的（+）-对映体，比(-)-对映体Nutlin-3a作用效果低150倍。	Electrophoresis, 2015, 36(24):3101-4	Dissociative effect of Nutlin-3a, Nutlin-3b, and RO-5963 on the preformed p53·MDM2 complex. Representative electrophoresis polyacrylamide gels in nondenaturing conditions for the analysis of the dissociation power of the inhibitors tested. (A) The reaction mixture containing 25 M p53·MDM2 complex, treated in the absence (lane 3) or in the presence (lanes 4-14) of 0.040, 0.060, 0.080, 0.12, 0.33, 0.67, 1.33, 3.33, 6.67, 33.33, and 333.33 μM Nutlin-3a, respectively, were run on a 12% nondenaturing polyacrylamide gel. Thirty micromolar MDM2 and p53 was run alone in lanes 1 and 2, respectively. (B) As in (A), but using Nutlin-3b, at concentration of (lanes 4-14) of 1.33, 6.67, 13.33, 20.00, 66.67, 133.33, 266.67, 333.33, 400.00, 833.33, and 1666.67 μM. p53 and MDM2 (25 μM both) were run alone in lanes 1 and 2, respectively. (C) As in (A), but using RO-5963, at concentration of 0.10, 0.21, 0.42, 0.83, 1.67, 3.33, 8.33, 16.67, 33.33, 166.67, and 333.33 μM (lanes 4-14), respectively. (D) The percentage of the residual p53·MDM2 complex was reported in a semilogarithmic plot, at the corresponding concentration of Nutlin-3a (empty circles), RO-5963 (triangles), and Nutlin-3b (filled circles), respectively. (E) The percentage of MDM2 dissociated from the complex was reported as a function of the inhibitor concentration. Curve fitting was done using the hyperbolic function. Symbols as in (D).
S7649	MI-773 (SAR405838) MI-773 (SAR405838) 是一种口服生物有效的MDM2拮抗剂，K_i为0.88 nM。Phase 1。	EMBO J, 2019, 38(20):e102096 Cell Chem Biol, 2018, 25(6):761-774 Oncotarget, 2016, 7(50):82757-82769	A panel of four NB cell lines were seeded in six-well plates with indicated concentrations of SAR405838 and agar, and grown for 2 to 3 weeks. Cells were stained with crystal violet for 4 hours. Colonies were counted and colony numbers were represented as % vehicle ± S.D. with P < 0.05 (), P < 0.01 () or P < 0.001 (**) (Student's t-test, two-tailed) as indicated.
S7489	YH239-EE YH239-EE,YH239乙酯,是一种强效的 p53-MDM2 拮抗剂和细胞凋亡诱导剂。	Cell Stem Cell, 2018, 23(4):544-556

产品目录	产品描述	文献引用	实验数据
S2678	NSC 207895 NSC 207895抑制MDMX，IC50为2.5 μM，促进p53稳定/激活和DNA损伤，也调节MDM2（E3连接酶）。	Oncol Lett,2018, 15(2):1673-1679 Stem Cell Reports,2016, 7(6):1140-1151	Median overall survival of mice (n = 5 mice in vehicle and PYR-41; n = 4 mice in NSC group) inoculated with IOWA-1T xenografts were increased to 43 ± 0.5 and 39 ± 2 days with PYR-41 (PYR) and NSC-207895 (NSC), respectively, compared with a vehicle-treated control group 33 ± 1 days (*p < 0.05).
S8059	Nutlin-3a Nutlin-3a是Nutlin-3的活性对映体，抑制p53/MDM2相互作用，无细胞试验中IC50为90 nM。	Cell Stem Cell,2019, 25(2):258-272 PLoS Pathog,2019, 15(2):e1007442 Cell Death Dis,2019, 10(4):282	Nutlin-3a preserved p53 expression without influencing high glucose (HG)-induced podocyte impairment. A-D: cultured podocytes were pre-treated by nutlin-3a for 2 hrs before subjected to HG treatment. Western blotting gel documents (A) and summarized data (B) showing the expression of p53 and MDM2 in podocytes under HG exposure for 24 hrs. n = 4. Western blotting gel documents (C) and summarized data (D) showing the expression of Desmin in podocytes under HG exposure for 24 hrs. n = 3. *P < 0.05 vs. Ctrl, #P < 0.05 vs. Vehl + HG. Ctrl: control; Vehl: vehicle; nutlin-3a: nutlin-3a treatment.
S7030	RG-7112 RG7112 (RO5045337)是一种口服具有活性的选择性p53-MDM2抑制剂，HTRF IC50为18 nM。	Nat Commun,2019, 10(1):2189 Cancer Biother Radiopharm,2019, 34(4):252-257 Nat Commun,2018, 9(1):2024
S8703^New	Milademetan (DS-3032b) Milademetan (DS-3032b) is a novel potent MDM2 inhibitor that inhibits MDM2-p53 interaction with an IC50 of 5.57 nM in the HTRF assay.
S7875	NVP-CGM097 NVP-CGM097是一种高效的、选择性的MDM2抑制剂， Ki值为1.3 nM。它与MDM2蛋白的p53结合位点结合，破坏其蛋白间相互作用，导致p53通路的激活。	Viruses,2019, 11(8) Mol Pharmacol,2016, 89(2):233-42 Carcinogenesis,2013, 34(2):436-45	(C) SACi2 effects are dependent on MT-kinetochore attachments. The graph shows percentage of cells undergoing forced mitotic exit by SACi2 or DMSO in various pretreatment conditions (mean ± SEM, three independent assays). Nocodazole (Noc) was used at 70 nM and 3 μM, vinblastine (Vbl) at 1 μM, taxol (Tx) at 600 nM and monastrol (Mon) at 100 μM concentrations and were added 8 h before addition of DMSO or SACi2. MG132 (20 μM) was added 1 h before nocodazole.
S8403	MX69 MX69是MDM2/XIAP抑制剂，其结合MDM2 RING 蛋白的Kd值为2.34 μM。用于治疗癌症。
S8606	HDM201,Siremadlin HDM201是一种新型的、高效的、选择性的p53-Mdm2 interaction抑制剂，对Mdm2的亲合常数在皮摩尔范围内，对Mdm2的选择性是对Mdm4的1000倍以上。
S7205	Idasanutlin (RG-7388) Idasanutlin (RG-7388)是一种有效的选择性p53-MDM2抑制剂,其IC50为6 nM。其体外结合力和在细胞中的效力、选择性都有极大的改善。	Cancer Cell,2019, 35(2):204-220 Cells,2019, 8(6) Nat Commun,2018, 9(1):2024
S2341	(-)-Parthenolide (-)-Parthenolide, Nuclear Factor-κB抑制剂，可特异性地耗尽HDAC1蛋白，而不影响其他I/II类 HDACs。促进MDM2的泛素化并激活p53的细胞功能。	Br J Haematol,2019, 187(1):49-64 Biochem Biophys Res Commun,2018, 501(1):246-252 Oncol Rep,2018, 39(3):1181-1190	G. To evaluate effects of IKBKE/TBK1 inhibition on NF-κB signaling in Ewing, TC32 cells were incubated with CYT387 for six hours prior to stimulation with TNF-α (30 ng/mL). IκBα degradation was measured by harvesting TC32 cells thirty minutes after stimulation with TNF-α. TNF-α stimulation resulted in degradation of IκBα, and this effect was attenuated with CYT387 treatment. Parthenolide, an inhibitor of IκBα phosphorylation was used as a positive control. Similar effects of CYT387 activity were seen in HEK-293T cells which also express IKBKΕ. Nuclear extracts were prepared from TC32 cells harvested following forty-five minutes of TNF-α stimulation. Treatment with CYT387 resulted in decreased nuclear localization of NF-κB family proteins RelA/p65 and c-Rel. There was a modest impairment of p50 nuclear localization as compared to parthenolide and DMSO controls and no change in p52 nuclear localization. RelB (not shown) is not expressed in TC32 cells

产品目录	产品描述	文献引用	实验数据
S1061	Nutlin-3 Nutlin-3是一种有效的，选择性Mdm2(它自身和p53的环指依赖性泛素蛋白连接酶)拮抗剂，无细胞试验中IC50为90 nM；可稳定p53缺陷细胞中的p73。	Virology, 2020, 539:1-10 Cell Rep, 2019, 29(5):1249-1260 Cell Death Differ, 2019, 10.1038/s41418-019-0338-1	Ubiquitination of p53 in vivo by BIRC6 in the presence of Nutlin-3. Cells were treated with Nutlin-3 (20 uM, 24 h) before harvest. Cell lysates were immunoprecipitated with anti-p53 antibody and immunoblotted by anti-ubiquitin antibody.
S8065	Nutlin-3b Nutlin-3b是一种p53/MDM2拮抗剂或抑制剂，IC50值为13.6μM，是Nutlin-3的（+）-对映体，比(-)-对映体Nutlin-3a作用效果低150倍。	Electrophoresis, 2015, 36(24):3101-4	Dissociative effect of Nutlin-3a, Nutlin-3b, and RO-5963 on the preformed p53·MDM2 complex. Representative electrophoresis polyacrylamide gels in nondenaturing conditions for the analysis of the dissociation power of the inhibitors tested. (A) The reaction mixture containing 25 M p53·MDM2 complex, treated in the absence (lane 3) or in the presence (lanes 4-14) of 0.040, 0.060, 0.080, 0.12, 0.33, 0.67, 1.33, 3.33, 6.67, 33.33, and 333.33 μM Nutlin-3a, respectively, were run on a 12% nondenaturing polyacrylamide gel. Thirty micromolar MDM2 and p53 was run alone in lanes 1 and 2, respectively. (B) As in (A), but using Nutlin-3b, at concentration of (lanes 4-14) of 1.33, 6.67, 13.33, 20.00, 66.67, 133.33, 266.67, 333.33, 400.00, 833.33, and 1666.67 μM. p53 and MDM2 (25 μM both) were run alone in lanes 1 and 2, respectively. (C) As in (A), but using RO-5963, at concentration of 0.10, 0.21, 0.42, 0.83, 1.67, 3.33, 8.33, 16.67, 33.33, 166.67, and 333.33 μM (lanes 4-14), respectively. (D) The percentage of the residual p53·MDM2 complex was reported in a semilogarithmic plot, at the corresponding concentration of Nutlin-3a (empty circles), RO-5963 (triangles), and Nutlin-3b (filled circles), respectively. (E) The percentage of MDM2 dissociated from the complex was reported as a function of the inhibitor concentration. Curve fitting was done using the hyperbolic function. Symbols as in (D).
S7649	MI-773 (SAR405838) MI-773 (SAR405838) 是一种口服生物有效的MDM2拮抗剂，K_i为0.88 nM。Phase 1。	EMBO J, 2019, 38(20):e102096 Cell Chem Biol, 2018, 25(6):761-774 Oncotarget, 2016, 7(50):82757-82769	A panel of four NB cell lines were seeded in six-well plates with indicated concentrations of SAR405838 and agar, and grown for 2 to 3 weeks. Cells were stained with crystal violet for 4 hours. Colonies were counted and colony numbers were represented as % vehicle ± S.D. with P < 0.05 (), P < 0.01 () or P < 0.001 (**) (Student's t-test, two-tailed) as indicated.
S7489	YH239-EE YH239-EE,YH239乙酯,是一种强效的 p53-MDM2 拮抗剂和细胞凋亡诱导剂。	Cell Stem Cell, 2018, 23(4):544-556